Dennis J. Carlo
Net Worth
Last updated:
What is Dennis J. Carlo net worth?
The estimated net worth of Dr. Dennis J. Carlo is at least $14,886,125 as of 25 May 2022. He has earned $143,975 from insider trading and has received compensation worth at least $14,742,150 in Adamis Pharmaceuticals Corporation.
What is the salary of Dennis J. Carlo?
Dr. Dennis J. Carlo salary is $982,810 per year as Pres, Chief Executive Officer & Director in Adamis Pharmaceuticals Corporation.
How old is Dennis J. Carlo?
Dr. Dennis J. Carlo is 82 years old, born in 1943.
What stocks does Dennis J. Carlo currently own?
As insider, Dr. Dennis J. Carlo owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Adamis Pharmaceuticals Corporation (ADMP) | Pres, Chief Executive Officer & Director | 285,867 | $0 | $0 |
What does Adamis Pharmaceuticals Corporation do?
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emergency treatment of acute allergic reactions, including anaphylaxis; dry powder inhaler products for the treatment of asthma; and naloxone injection for the treatment of opioid overdose. It also offers APC400, a tempol gel use of reducing radiation dermatitis in patients undergoing treatment for cancer; and APC410 for the treatment of respiratory diseases, including asthma, respiratory syncytial virus, influenza, and COVID-19. In addition, the company provides corticosteroids, hormone replacement therapies, hospital outsourcing products, and injectables; and veterinary pharmaceutical products for animals. Adamis Pharmaceuticals Corporation was founded in 2006 and is headquartered in San Diego, California.
Dennis J. Carlo insider trading
Adamis Pharmaceuticals Corporation
Dr. Dennis J. Carlo has made 11 insider trades between 2010-2022, according to the Form 4 filled with the SEC.
The largest trade he's ever made was exercising 975,000 units of ADMP stock on 20 Aug 2010. As of 25 May 2022 he still owns at least 285,867 units of ADMP stock.
Adamis Pharmaceuticals key executives
Adamis Pharmaceuticals Corporation executives and other stock owners filed with the SEC:
- Dr. Dennis J. Carlo (82) Pres, Chief Executive Officer & Director
- Dr. Ronald B. Moss (64) Chief Medical Officer